TG Therapeutics News

TG Therapeutics | 8-K: Current report

Jun 17 16:51 ET

TG Therapeutics | DEFA14A: Others

Apr 29 16:42 ET

TG Therapeutics | DEF 14A: Definitive information statements

Apr 29 16:39 ET

TG Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 18 16:58 ET

TG Therapeutics | 8-K: Current report

Jan 10 00:00 ET

TG Therapeutics | 8-K: Current report

Jun 15, 2023 16:30 ET

TG Therapeutics | DEFA14A: Others

May 1, 2023 16:19 ET

TG Therapeutics | DEF 14A: Definitive proxy statements

May 1, 2023 16:17 ET

TG Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 21, 2023 16:30 ET

TG Therapeutics | 8-K: Current report

Dec 28, 2022 16:30 ET

TG Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Sep 2, 2022 16:31 ET

TG Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 24, 2022 17:10 ET

TG Therapeutics | 8-K: Current report

Jun 23, 2022 16:31 ET

TG Therapeutics | DEFA14A: Others

Apr 29, 2022 16:11 ET

TG Therapeutics | DEF 14A: Definitive proxy statements

Apr 29, 2022 16:06 ET

TG Therapeutics | 8-K: Current report

Apr 18, 2022 07:30 ET

TG Therapeutics | 8-K: Current report

Jan 27, 2022 10:01 ET

TG Therapeutics | 8-K: Current report

Jan 4, 2022 07:39 ET

TG Therapeutics | 8-K: Current report

Nov 30, 2021 07:59 ET

TG Therapeutics | 8-K: Current report

Nov 4, 2021 07:27 ET